Subscribe to Whitney RSS feed

Whitney

New Alzheimer's trial seeking participants

A new approach to Alzheimer‘s disease is taking place at the Cleveland Clinic Lou Ruvo Center for Brain Health. Since the first of the year, it‘€™s been recruiting participants for a new clinical trial, the Anti-Amyloid Treatment in Asymptomatic Alzheimer‘s study, or A4. The study investigates whether treating older individuals with an investigational drug, dubbed solanezumab, can delay memory decline in those who may be at risk to develop Alzheimer‘s disease.